Abstract
Companies are engineering B cells to produce gene-encoded medicines, but clinical proof of concept is needed to convince the doubters that this platform can deliver.
Cite
CITATION STYLE
APA
Sheridan, C. (2024, June 1). B cells as drug factories. Nature Biotechnology. Nature Research. https://doi.org/10.1038/s41587-024-02283-3
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free